47.73.Z - Retail sale of pharmaceutical products
20.42.Z - Manufacture of cosmetics and toilet preparations
20.53.Z - Manufacture of chemicals and chemical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
26.20.Z - Manufacture of computers and peripheral equipment
27.40.Z - Manufacture of lighting equipment
33.12.Z - Repair and maintenance of machinery
33.13.Z - Repair and maintenance of electronic and optical devices
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.51.Z - Wholesale trade
46.66.Z - Wholesale trade
47.25.Z - Retail trade of alcoholic and non-alcoholic beverages
47.29.Z - Retail trade
47.41.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.78.Z - Retail sale of other new products
47.91.Z - Intermediary retail sale, non-specialized
62.01.Z - Activities related to programming, IT consulting, and related activities
62.02.Z - Activities related to programming, IT consulting, and related activities
62.03.Z - Activities related to programming, IT consulting, and related activities
62.09.Z - Activities related to programming, IT consulting, and related activities
63.11.Z - Services related to computing infrastructure, data processing, website management (hosting), and other information services
64.92.Z - Other forms of credit granting
68.20.Z - Rental and management of own or leased real estate
73.11.Z - Advertising agency activities
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0 | 174 | ||
Gross profit (loss) | 0,1 | -0 | 0,1 | 904,6 |
EBITDA | 0,1 | 203,4 | ||
Short time liabilities | 0 | -60,3 | ||
Income tax | 0 | 0 | 0 | |
Other operating costs | 0 | 16,9 | ||
Equity capital | 0,5 | 0,5 | 0,6 | 9,6 |
Operating profit (EBIT) | 0,1 | 200,7 | ||
Assets | 0,6 | 0,6 | 0,6 | 5,5 |
Net profit (loss) | 0,1 | -0 | 0,1 | 904,6 |
Cash | 0,2 | -∞ | ||
Net income from sale | 2,6 | -8,4 | ||
Liabilities and provisions for liabilities | 0 | 0 | 0 | -56,9 |
Working assets | 0,6 | 0,6 | 0,6 | 7,1 |
Other income costs | 0,1 | 154,3 | ||
Basic operational activity income | 2,8 | 2,7 | -1,8 | |
Depreciation | 0 | 277,5 | ||
% | % | % | p.p. | |
Profitability of capital | 15 | -1,2 | 8,7 | 9,9 |
Equity capital to total assets | 93,3 | 93,9 | 97,5 | 3,6 |
Gross profit margin | 3,1 | -0,2 | 1,9 | 2,1 |
EBITDA Margin | 3,2 | 2,2 | ||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 5 | -7 | ||
Current financial liquidity indicator | 14.94884967803955 | 9,2 | ||
Net dept to EBITDA | -2.8716390132904053 | -2,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane